Adverse events and GI side effects, though not serious, prompted a significant number of people in the studies to stop taking semaglutide
Read the full FLOW trial results and Plain Language Summary: #ClinicalTrials #MedicalResearch NEJM Groups Post Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death
Ingredients Active Ingredient: semaglutide Ozempic Injection Inactive Ingredients: disodium phosphate dihydrate, propylene glycol, phenol, and water for injection
Given the safety, efficacy, and cost advantage compared to newer drugs, guidelines support metformin as a first-line treatment for most diabetes patients
In case of intolerable side effects, they may switch to other GLP-1 medications, such as liraglutide, tirzepatide (Mounjaro or Zepbound), or dulaglutide
Is semaglutide left out overnight still usable